Outlook Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,680
Closed -$653K 300
2025
Q2
$653K Buy
1,680
+5
+0.3% +$2.01K 0.17% 120
2025
Q1
$728K Sell
1,675
-6
-0.4% -$2.41K 0.2% 99
2024
Q4
$620K Buy
1,681
+7
+0.4% +$2.93K 0.18% 115
2024
Q3
$871K Sell
1,674
-19
-1% -$10.2K 0.25% 79
2024
Q2
$918K Sell
1,693
-18
-1% -$9.51K 0.29% 70
2024
Q1
$887K Sell
1,711
-90
-5% -$44.8K 0.27% 74
2023
Q4
$849K Sell
1,801
-301
-14% -$139K 0.3% 66
2023
Q3
$915K Buy
2,102
+39
+2% +$17.7K 0.35% 67
2023
Q2
$917K Buy
2,063
+276
+15% +$127K 0.35% 68
2023
Q1
$822K Buy
1,787
+1,322
+284% +$629K 0.37% 65
2022
Q4
$239K Hold
465
0.11% 155
2022
Q3
$211K Hold
465
0.09% 171
2022
Q2
$224K Buy
465
+11
+2% +$5.44K 0.09% 177
2022
Q1
$223K Sell
454
-9
-2% -$4.11K 0.07% 189
2021
Q4
$215K Buy
+463
New +$195K 0.06% 193

Other funds holding ELV

Outlook Wealth Advisors's ELV Position: Q3 2025 in Review

Outlook Wealth Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,680 shares — an estimated $653K sold.

Outlook Wealth Advisors first reported a position in ELV in Q4 2021 and held it in 15 quarters. The position peaked at $918K in Q2 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Outlook Wealth Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Outlook Wealth Advisors sold 1,680 Elevance Health shares in Q3 2025, an estimated $653K.
  • Outlook Wealth Advisors first reported a position in Elevance Health in Q4 2021 and held it in 15 quarters.
  • Outlook Wealth Advisors's Elevance Health position peaked at $918K in Q2 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Outlook Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.